Maternal OM‐85 administration alleviates offspring allergic airway inflammation by downregulating IL‐33/ILC2 axis
Pediatric Allergy and Immunology · 2025-02 · 36 (2)
DOI: 10.1111/pai.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 10.02.2025. Verfasst von Wei Zou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China. Hauptthemen laut MEDLINE: Interleukin-33, Lymphocytes, Asthma, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Zhuhai Science and Technology Plan Project, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Background
Type 2 innate lymphoid cells (ILC2s) are essential for maintaining immune regulation and promoting tissue homeostasis in allergic asthma. How the development of gut microbiota on neonatal ILC2s influences allergic airway inflammation remains unclear. Here we focus on offspring ILC2 development in the context of alterations in maternal gut microbiota.
Methods
C57BL/6 maternal mice were gavaged with OM‐85 during pregnancy and/or lactation, ILC2‐driven allergic airway inflammation in the OVA‐sensitized adult offspring was observed. ILC2 development in offspring early life were investigated using recombinant (r)IL‐33, rIL‐25 and Bromodeoxyuridine in the vivo experiments. Further ILC2 promoting factors‐ IL‐33 and IL‐25 production in offspring early life were analysed. Finally, we examined the changes in gut microbiota and its metabolites in both dams and pups, and explored the effects of short‐chain fatty acids (SCFAs) on IL‐33 expression and secretion.
Results
Maternal OM‐85 administration restrained ILC2‐driven allergic airway inflammation in the OVA‐sensitized adult offspring. During ILC2 development in offspring early life, maternal OM‐85 administration suppressed IL‐33 and IL‐25 production to inhibit ILC2 expansion and ILC2 responsiveness to alarmins, and infantile ILC2s could persist into adulthood. Maternal OM‐85 administration increased SCFAs in breast milk and SCFA‐producing gut probiotics (predominant Bacteroides and Blautia ) in offspring, especially during pregnancy and lactation. SCFAs down‐regulated IL‐33 expression and reduced IL‐33 secretion by inhibited gasdermin D (GSDMD) formation.
Conclusion
Maternal OM‐85 administration restrains ILC2‐driven allergic airway inflammation in adult offspring by increasing offspring intestinal SCFAs to modulate ILC2 development at an early stage, demonstrating that the transgenerational effects of maternal OM‐85 exposure on offspring innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
- Department of Thoracic Oncology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
- Department of Gastroenterology, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
- Oncology Central Laboratory, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
- Department of Neurosurgery, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China.
ORCID-Profile: Jing Liu
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Zhuhai Science and Technology Plan Project
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zou, W., Ma, D., Sun, F., Chen, Z., Chen, Y., Li, X., Chen, M., Lin, M., Shi, H., Wu, B., Chen, L., Liang, Z., & Liu, J. (2025). Maternal OM‐85 administration alleviates offspring allergic airway inflammation by downregulating IL‐33/ILC2 axis. Pediatric Allergy and Immunology, 36(2). https://doi.org/10.1111/pai.70044
Vancouver
Zou W, Ma D, Sun F, Chen Z, Chen Y, Li X, et al. Maternal OM‐85 administration alleviates offspring allergic airway inflammation by downregulating IL‐33/ILC2 axis. Pediatric Allergy and Immunology. 2025;36(2). doi:10.1111/pai.70044
BibTeX
@article{Zou2025,
author = {Zou, Wei and Ma, Donghai and Sun, Fengfei and Chen, Zehu and Chen, Ying and Li, Xuegang and Chen, Meizhu and Lin, Minmin and Shi, Honglei and Wu, Baihe and Chen, Lei and Liang, Zibin and Liu, Jing},
title = {Maternal OM‐85 administration alleviates offspring allergic airway inflammation by downregulating IL‐33/ILC2 axis},
journal = {Pediatric Allergy and Immunology},
year = {2025},
volume = {36},
number = {2},
doi = {10.1111/pai.70044}
}
EUVIMED